Kerensa Broersen

A comparative analysis of the aggregation behavior of amyloid-β peptide variants.

Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio.

Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease.

The mechanism of γ-Secretase dysfunction in familial Alzheimer disease.

Molecular plasticity regulates oligomerization and cytotoxicity of the multipeptide-length amyloid-β peptide pool.

New mimetic peptides inhibitors of Αβ aggregation. Molecular guidance for rational drug design.

Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes.

Could ecosystem management provide a new framework for Alzheimer's disease?

Characterization of insulin-degrading enzyme-mediated cleavage of Aβ in distinct aggregation states.

Optimized Triton X-114 assisted lipopolysaccharide (LPS) removal method reveals the immunomodulatory effect of food proteins.

Structural and Aggregation Properties of Alpha-Synuclein Linked to Phospholipase A2 Action.

Searching for improved mimetic peptides inhibitors preventing conformational transition of amyloid-β monomer.

Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound.

Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation.

Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.

Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4V.

Milk Processing Affects Structure, Bioavailability and Immunogenicity of β-lactoglobulin.

Plant isoquinoline alkaloids as potential neurodrugs: A comparative study of the effects of benzo[c]phenanthridine and berberine-based compounds on β-amyloid aggregation.

Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins.

A Review of Oxidative Stress Products and Related Genes in Early Alzheimer's Disease.

Engineering Organoids for Modeling of Phenylketonuria.

Use of standard U-bottom and V-bottom well plates to generate neuroepithelial embryoid bodies.

Alzheimer's Disease: Treatment Strategies and Their Limitations.